Publications by authors named "Xing-Yu Mu"

Claim this Profile
1
18F-FDG PET/CT radiomics for distinguishing LUAD from LUSC in non-small cell lung cancer.
Jie Qin, Zhao Ge, Yu Long Zeng, Jing Ze Li, Xing Yu Mu

Medicine (Baltimore)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic immune-inflammation index and all-cause and cause-specific mortality in sarcopenia: a study from National Health and Nutrition Examination Survey 1999-2018.
Qing-Yue Zeng, Yu Qin, Yi Shi, Xing-Yu Mu, Shi-Jun Huang

Front Immunol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and evaluation of a CT-based radiomic model for AIDS-associated pulmonary cryptococcosis.
Zi-Xin Zhang, Xing-Yu Mu, Jing Yu, Chun-Shuang Guan, Bu-Dong Chen

BMC Med Imaging· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Effect of Social Support on Multimorbidity and Related Outcomes of Middle-Aged and Older Adults in China].
Xing-Yu Mu, Min-Jun Zhao, Tian-Pei Ma, Jiao Xu, Yi Shi

Sichuan Da Xue Xue Bao Yi Xue Ban· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Subacute Thyroiditis Following HPV Vaccination: A Case Report].
Qian Xie, Xing-Yu Mu, Shuang-Qing Li

Sichuan Da Xue Xue Bao Yi Xue Ban· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative CD4CD25/CD4 and tumor diameter predict prognosis in male patients with bladder cancer.
Ren-Jie Wang, Wei Liu, Xing-Yu Mu, Zhi-Xian Yao, Ke Wu

Biomark Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RS 504393 inhibits M-MDSCs recruiting in immune microenvironment of bladder cancer after gemcitabine treatment.
Xing-Yu Mu, Ren-Jie Wang, Zhi-Xian Yao, Zhong Zheng, Jun-Tao Jiang

Mol Immunol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural and Functional Insights into PpgL, a Metal-Independent β-Propeller Gluconolactonase That Contributes to Virulence.
Ying-Jie Song, Kai-Lun Wang, Ya-Lin Shen, Jie Gao, Tao Li, Xing-Yu Mu

Infect Immun· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miRNA‑26a‑5p and miR‑26b‑5p inhibit the proliferation of bladder cancer cells by regulating PDCD10.
Ke Wu, Xing-Yu Mu, Jun-Tao Jiang, Ming-Yue Tan, Ren-Jie Wang

Oncol Rep· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin inhibits the progression of bladder cancer by selectively depleting G-MDSCs: A novel chemoimmunomodulating strategy.
Ke Wu, Ming-Yue Tan, Jun-Tao Jiang, Xing-Yu Mu, Jie-Ren Wang

Clin Immunol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term use of ciclosporin on kidney transplant recipients surviving more than 10 years.
Yan Qin, Yu Fan, XingYu Mu, Fang Zhang, Bing Shen

Pharmazie· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SUMO-specific protease 2 suppresses cell migration and invasion through inhibiting the expression of MMP13 in bladder cancer cells.
Ming-Yue Tan, Xing-Yu Mu, Bin Liu, Yong Wang, Er-Dun Bao

Cell Physiol Biochem· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis